Ambrosiabiosciences

Series-B
ambrosiabiosciences.com Biotech & Healthcare Boulder, United States
Total Funding Undisclosed
Latest Round Undisclosed Series-B
Last Announced Mar 31, 2026
Investors 8 Backers
Decision Makers Profile Active

About Ambrosiabiosciences

Our scientific team brings deep expertise across every stage of structure-based drug discovery, with contributions to 30 IND filings, 25 new molecular entities, and 7 FDA approvals.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Boulder, United States
Tracked Since Nov 6, 2026

Web & Domain Identity

Official Website ambrosiabiosciences.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @ambrosiabio (7 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised undisclosed · Series-B

    fundraisingfox.com

Investors & Backers

8
Biotechnology Value Fund
Blue Owl Capital
Boulder Ventures
Deep Track Capital
Janus Henderson Investors
Merck
Redmile Group
Samsara Biocapital

Funding History

1 Round
Series-B equity · Mar 31, 2026

Founders & Leadership

4

Faraz Naqvi

Founder and Medical Director

Work email & phone locked Unlock →

Kyle Lefkoff

Founder and Chairman

Work email & phone locked Unlock →

Linda Shapiro Manning

Chief Medical Officer

Work email & phone locked Unlock →

Nick Traggis

Founder and Chief Executive Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts